Recent Articles from GlobeNewswire

East Hanover, April 24, 2026 – Novartis today announced that the World Health Organization (WHO) has prequalified Coartem® (artemether-lumefantrine) Baby, the first and only antimalarial developed specifically for newborns and young infants weighing from 2 to 5 kilograms. The decision is a key step towards enabling widespread access through public sector procurement. Coartem Baby is also known as Riamet® Baby in some countries and was developed in collaboration with Medicines for Malaria Venture (MMV).“This new formulation of artemether-lumefantrine represents an innovation as there are no antimalarial medicines specifically developed for the treatment of uncomplicated malaria in children from 2 to 5 kilograms body weight,” said Dr Daniel Ngamije Madandi, Director, Malaria and Neglected Tropical Diseases at the WHO.Prequalification is a process run by the WHO to assess the quality, safety and efficacy of treatments for diseases like malaria, HIV/AIDS and tuberculosis. Prequalification outputs, including lists of prequalified products, are used by United Nations and other procurement agencies to inform funding and purchasing decisions for the public sector.1 Novartis is making the treatment available on largely not-for-profit basis in malaria-endemic regions.“This decision takes us one step closer to ensuring that the tiniest babies have access to the first antimalarial designed specifically for them,” said Dr Lutz Hegemann, President of Global Health at Novartis. “We have already introduced the treatment in Ghana and are pleased to now be going further together with our partners to reach even more of the smallest malaria patients.”Until recently, there has been no approved malaria treatment for infants weighing less than 4.5 kilograms, leaving a treatment gap. The smallest infants with malaria have instead been treated with formulations intended for use in older children, which may increase the risk of side effects and toxicity.“As doctors we’ve tended to look for malaria in older children, but when newborn babies got sick nobody seemed to know what to do,” said Dr Emmanuel Aidoo, a pediatrician at Methodist Hospital in Ankaase, Ghana. “Having a new treatment tailor-made for infants that is well tolerated gives us confidence.”Coartem Baby was developed by Novartis with the scientific and financial support of MMV, and as part of the PAMAfrica consortium, which is co-funded by the European & Developing Countries Clinical Trials Partnership and the Swedish International Development Cooperation Agency.“For too long, newborns and young infants with malaria have fallen through the cracks because existing treatments were not designed with them in mind,” said Dr Martin Fitchet, CEO of MMV. “WHO prequalification of Coartem Baby is a major public health milestone and reflects MMV’s commitment to ensuring that even the smallest and most vulnerable patients are not left behind. This achievement shows what is possible when partners come together to translate scientific innovation into real‑world impact.”About malaria  Malaria is a life-threatening disease caused by a parasite and spread to humans by some types of mosquitoes. According to the most recent WHO data, there 282 million cases and 610,000 deaths in 2024 – roughly 9 million more cases than the previous year – almost all of them in Africa. Children under 5 years old accounted for about three in four malaria deaths in the region.2 However, current data on malaria in the youngest babies is extremely limited as they are rarely included in clinical trials of antimalarial agents.3,4 Some 30 million babies are born in areas of malaria risk in Africa every year,5 with one large survey across West Africa reporting infections ranging between 3.4% and 18.4% in infants younger than 6 months old.6  About Novartis in malaria innovation  Novartis has built the industry’s largest pipeline of treatments to control or eliminate malaria and neglected tropical diseases,7 backed by more than USD 500 million in funding for global health R&D since 2021. This includes four new non-artemisinin antimalarial compounds with the potential to combat rising drug resistance. Novartis has delivered more than 1.1 billion treatment courses of its antimalarial Coartem since 1999, largely at no profit. About MMV MMV is a Swiss non-profit product development partnership. MMV works “end-to-end” to discover, develop and deliver affordable and accessible medicines to treat, prevent and eliminate malaria. Since 1999, over 1.3 billion people have benefited from MMV’s co-developed medicines. With malaria still killing 600,000 each year, MMV brings partners together to close the remaining gaps in antimalarial access and innovation.  For more information, visit www.mmv.org. Follow MMV on social media: X, LinkedIn, YouTube and Facebook  DisclaimerThis press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as “potential,” “can,” “will,” “plan,” “may,” “could,” “would,” “expect,” “anticipate,” “look forward,” “believe,” “committed,” “investigational,” “pipeline,” “launch,” or similar terms, or by express or implied discussions regarding potential marketing approvals, new indications or labeling for the investigational or approved products described in this press release, or regarding potential future revenues from such products. You should not place undue reliance on these statements. Such forward-looking statements are based on our current beliefs and expectations regarding future events, and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. There can be no guarantee that the investigational or approved products described in this press release will be submitted or approved for sale or for any additional indications or labeling in any market, or at any particular time. Nor can there be any guarantee that such products will be commercially successful in the future. In particular, our expectations regarding such products could be affected by, among other things, the uncertainties inherent in research and development, including clinical trial results and additional analysis of existing clinical data; regulatory actions or delays or government regulation generally; global trends toward health care cost containment, including government, payor and general public pricing and reimbursement pressures and requirements for increased pricing transparency; our ability to obtain or maintain proprietary intellectual property protection; the particular prescribing preferences of physicians and patients; general political, economic and business conditions, including the effects of and efforts to mitigate pandemic diseases; safety, quality, data integrity or manufacturing issues; potential or actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors referred to in Novartis AG’s current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.About Novartis Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 300 million people worldwide.Reimagine medicine with us: Visit us at https://www.novartis.us and connect with us on LinkedIn US, X/Twitter US and Instagram US.References

Recognized for innovation in compliance automation and purpose-built technology for the health and benefits insurance industry

Groundbreaking AAV-based gene therapy offers potential treatment for patients with OTOF gene-associated severe-to-profound and profound hearing loss

NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased New Era Energy & Digital, Inc. (“New Era” or the “Company”) (NASDAQ:NUAI) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

LOS ANGELES, April 23, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of AsiaStrategy (“AsiaStrategy” or “the Company”) (NASDAQ: SORA) for violations of the securities laws.

LOS ANGELES, April 23, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Basel Medical Group Ltd (“Basel” or “the Company”) (NASDAQ: BMGL) for violations of the securities laws.

FireFly shareholders are expected to receive one Bellavista share for every 12.8 FireFly shares held, ensuring shareholders retain ongoing exposure to the assets and their exploration upside, while FireFly targets ongoing growth at its flagship Green Bay Copper-Gold Project

LOS ANGELES, April 23, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of BeLive Holdings (“BeLive” or “the Company”) (NASDAQ: BLIV) for violations of the securities laws.

Calls it an ‘affront’ to American workers and warns it ‘sabotages’ the Trump maritime dominance agenda

-- Cash and Cash Investments at December 31, 2025 of €116.5 Million and Gross Proceeds of $208 Million from Initial Public Offering (IPO) Expected to Extend Cash Runway into First Half of 2029 --

LOS ANGELES, April 23, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Perimeter Solutions, Inc. (“Perimete” or “the Company”) (NYSE: PRM) for violations of the securities laws.

NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Upstart Holdings, Inc. (“Upstart” or the “Company”) (NASDAQ:UPST) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

Denver, Colo., April 23, 2026 (GLOBE NEWSWIRE) -- The Trump administration’s Fiscal Year (FY) 2027 budget proposal maintains the maximum Pell Grant of $7,395 and provides adequate funding to address the current funding shortfall (read the U.S. Department of Education 2027 budget summary). This is good news in the wake of last year’s budget proposal to cut the maximum Pell grant to $5,710 (nearly a quarter of the current grant). Maintaining Pell Grants is important, as they serve students with great financial need. Still, the value of the grant has not kept pace with today’s dollars due to inflation. There needs to be at least another $713 in funding for each Pell award to keep up with inflation. 

LOS ANGELES, April 23, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against LKQ Corporation (“LKQ” or “the Company”) (NASDAQ: LKQ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nano-X (NNOX) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Sportradar (SRAD) To Contact Him Directly To Discuss Their Options

TORONTO, April 23, 2026 (GLOBE NEWSWIRE) -- Martinrea International Inc. (TSX : MRE) today announced it will report its financial results for the first quarter ended March 31, 2026 on Thursday, April 30, 2026 at 4:30 p.m. Eastern Time. The Company will hold a conference call to discuss the results the same day at 5:30 p.m. Eastern Time. To participate, please dial 416-855-9085 (Toronto area) or 800-990-2777 (toll free Canada and US) and enter participant code 16073#. Please call 10 minutes prior to the start of the conference call.

(All amounts expressed in US dollars, unless otherwise stated)

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In LKQ To Contact Him Directly To Discuss Their Options

CULVER CITY, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, today announced a major milestone in its long-term growth strategy with the release of a new developer diary for For The Stars, offering investors and media an in-depth look at the game’s current development progress, including new pre-alpha footage and previously unreleased concept art.

LOUISVILLE, Ky., April 23, 2026 (GLOBE NEWSWIRE) -- In response to today’s announcement from the University of Louisville regarding its reconciliation with Papa John’s International founder John Schnatter, Mr. Schnatter issued the following statement:

2025 brought enhanced liquidity through completed Light Duty divestiture, the launch of GFI branded production in China and Canada, new HPDI™ OEM interest and global market traction for Cespira

TORONTO, April 23, 2026 (GLOBE NEWSWIRE) -- Timbercreek Financial Corp. (TSX: TF) (the “Company” or “Timbercreek Financial”) is pleased to announce that it has declared a monthly cash dividend of $0.0575 per common share (“Common Share”) of the Company to be paid on May 15, 2026 to holders of Common Shares of record on April 30, 2026.

HOUSTON and LONDON, April 23, 2026 (GLOBE NEWSWIRE) -- Baker Hughes Company (Nasdaq: BKR) ("Baker Hughes" or the "Company") announced results today for the first quarter of 2026.

CLEVELAND, April 23, 2026 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that its Board of Directors has declared a quarterly cash dividend of $2.00 per share of common stock to shareholders of record as of May 8, 2026. The dividend is payable June 5, 2026. The dividend represents an 11% increase over the previous quarterly cash dividend of $1.80 per common share and will be the 304th consecutive quarterly dividend paid by the company.

Founder and Chief Science Officer Honored for Scalable Manufacturing at Strata Biotech Labs Supporting Science‑Backed Wellness Products

SINGAPORE, April 23, 2026 (GLOBE NEWSWIRE) -- OIO Group (NASDAQ: OIO) (“OIO” or the “Company”) today announced the completion of its previously announced business combination with De Tomaso Automobili Holdings Limited (“De Tomaso”), resulting in a change of control of the Company.

MIAMI, April 23, 2026 (GLOBE NEWSWIRE) -- AerSale Corporation (NASDAQ: ASLE) (the “Company”), announced today that it will release its earnings results for the first quarter ended March 31, 2026, on Thursday, May 7, 2026, after the market closes. The Company will host a conference call on the same day at 4:30 pm Eastern Time to discuss the results.

MIAMI, April 23, 2026 (GLOBE NEWSWIRE) -- USCB Financial Holdings, Inc. (the “Company”) (NASDAQ: USCB), the holding company for U.S. Century Bank (the “Bank”), reported net income of $9.4 million or $0.51 per fully diluted share for the three months ended March 31, 2026, compared with net income of $7.7 million or $0.38 per fully diluted share for the same period in 2025.

EDISON, N.J., April 23, 2026 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) ("Eos" or the “Company”), an American energy company and the leading innovator in designing, sourcing, manufacturing, and providing zinc-based battery energy storage systems (BESS) manufactured in the United States, today announced it will release its first quarter 2026 financial results before the U.S. market opens on May 13, 2026. A conference call to discuss its results will take place the same morning at 8:30 a.m. Eastern Time.

NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Mercer International (NASDAQ: MERC) will release its first quarter results for the period ending March 31, 2026 on Thursday, April 30, 2026, after the close of the market. Juan Carlos Bueno, President and Chief Executive Officer and Richard Short, Chief Financial Officer and Secretary, will be hosting a conference call on Friday, May 1, 2026, at 10:00 am ET to discuss the results.

RED BANK, N.J., April 23, 2026 (GLOBE NEWSWIRE) -- OceanFirst Financial Corp. (NASDAQ:OCFC) (the “Company”), the holding company for OceanFirst Bank N.A. (the “Bank”), announced net income available to common stockholders of $20.5 million, or $0.36 per diluted share, for the quarter ended March 31, 2026, as compared to $20.5 million, or $0.35 per diluted share, for the corresponding prior year period, and compared to $13.1 million, or $0.23 per diluted share, for the linked quarter. Selected performance metrics are as follows (refer to “Selected Quarterly Financial Data” for additional information):

HOUSTON, April 23, 2026 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. (“NCS” or the “Company”) (NASDAQ:NCSM) will host a conference call to discuss its first quarter 2026 results on Thursday, April 30, 2026 at 7:30 a.m. Central Time (8:30 a.m. Eastern Time). NCS will issue its first quarter 2026 earnings release the evening prior to the conference call.

OMAHA, Neb., April 23, 2026 (GLOBE NEWSWIRE) -- Greystone Housing Impact Investors LP (NYSE: GHI) (the “Partnership”) announced today that it will host a conference call for investors on Tuesday, May 12, 2026 at 9:00 a.m. Eastern Time to discuss the Partnership’s First Quarter 2026 results.

Full-Year Guidance Increased Due To:

CINCINNATI, April 23, 2026 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation’s largest owners and operators of high-quality, grocery-anchored neighborhood shopping centers, today reported financial and operating results for the period ended March 31, 2026 and updated full year 2026 earnings guidance. For the three months ended March 31, 2026, net income attributable to stockholders was $30.4 million, or $0.24 per diluted share.

HAMILTON, Bermuda, April 23, 2026 (GLOBE NEWSWIRE) -- SiriusPoint Ltd. (NYSE: SPNT) (“SiriusPoint” or the “Company”) today announced that it is planning to release its first quarter 2026 financial results after the market close on Thursday, May 7, 2026. The Company will also hold a conference call, including a question-and-answer session, to discuss its financial results at 8:30 am (Eastern Time) on Friday, May 8, 2026.

St. Louis , April 23, 2026 (GLOBE NEWSWIRE) -- ESCO Technologies Inc. (NYSE:ESE) will report its second quarter financial results after the market close on Thursday, May 7, 2026, followed by a conference call where the financial results and related commentary will be discussed.  

SALT LAKE CITY, April 23, 2026 (GLOBE NEWSWIRE) -- Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company focused on the outdoor enthusiast markets, will hold a conference call on Thursday, May 7, 2026, at 5:00 pm ET to discuss its financial results for the first quarter ended March 31, 2026. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call.

DALLAS, April 23, 2026 (GLOBE NEWSWIRE) -- Dorchester Minerals, L.P. (NASDAQ:DMLP) announced today the Partnership’s first quarter 2026 cash distribution. The distribution of $0.475036 per common unit represents activity for the three-month period ended March 31, 2026 and is payable on May 14, 2026 to common unitholders of record as of May 4, 2026.

TULSA, Okla., April 23, 2026 (GLOBE NEWSWIRE) -- The board of directors of ONEOK, Inc. (NYSE: OKE) today declared a quarterly dividend of $1.07 per share, unchanged from the previous quarter, resulting in an annualized dividend of $4.28 per share.

Lima, April 23, 2026 (GLOBE NEWSWIRE) -- Lima, Peru, April 23, 2026 – Credicorp Ltd. (“Credicorp”) (NYSE: BAP | BVL: BAP) announces that, in accordance with its corporate disclosure policies, the Company will enter its quiet period for the first quarter 2026 earnings release beginning on April 30, in order to prevent any potential disclosure of financial information and to ensure fair and orderly dissemination. This period will end on the date of the earnings release, May 14. During the quiet period, the Company will not disclose any financial information, comment on financial results, or respond to related inquiries.

LONG BEACH, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced its next-generation High-Performance Star Tracker (ST-HP), designed to improve key performance metrics for longer duration spacecraft missions in low Earth orbit and beyond.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Boston Scientific (BSX) To Contact Him Directly To Discuss Their Options

VALENCIA, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company, today announced that it will report its first quarter 2026 financial results after the close of the U.S. financial markets on Thursday, May 14, 2026. AVITA Medical will host a conference call and webcast that day at 1:30 p.m. Pacific Time (Friday, May 15, 2026, at 6:30 a.m. Australian Eastern Standard Time) to discuss its financial results and recent business highlights.

HOUSTON and LONDON, April 23, 2026 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR) announced today that the Baker Hughes Board of Directors declared a quarterly cash dividend of $0.23 per share of Class A common stock payable on May 15, 2026, to holders of record on May 5, 2026.

Management to be Joined by Two Clinical Leaders in the Breast Cancer Field 

Recognition highlights ABM Connect as a breakthrough platform transforming facilities into intelligent, data-driven environments

AUSTIN, Texas, April 23, 2026 (GLOBE NEWSWIRE) -- Digital Realty (NYSE: DLR), the world’s largest cloud- and carrier-neutral data center platform, announced today financial results for the first quarter of 2026. All per share results are presented on a fully diluted basis.

Strong Revenue Growth and Margin Expansion Underscore an Impressive Start to 2026

2026 First-Quarter Financial Highlights

NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Peloton Interactive, Inc. (NASDAQ: PTON) will release its third quarter fiscal 2026 financial results before the U.S. stock market opens on Thursday, May 7, 2026. The company will host a conference call and live audio webcast to discuss the financial results at 8:30 a.m. ET that day.

VANCOUVER, Wash. and NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will report business updates and financial and operating results for the first quarter 2026 after market close on Thursday, May 7, 2026.

SANTA CLARA, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. (Nasdaq: SVCO) ("Silvaco" or the "Company"), a provider of TCAD, EDA software, and SIP solutions that enable innovative semiconductor design and digital twin modeling through AI software and automation, will release its financial results for the first quarter ended March 31, 2026, after the market close on Thursday, May 7, 2026. The company will host a conference call at 5:00 p.m. Eastern time to discuss its first quarter 2026 results and second quarter 2026 outlook.

BEIJING, China, April 23, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (the “Company” or “ITOC”), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today announced that on April 21, 2026, it received notification from The Nasdaq Stock Market LLC (“Nasdaq”) that Nasdaq approved the Company’s request for an extension of additional 180-calendar day, or until October 19, 2026 (the “Extension”) to regain compliance with the minimum closing bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”).The Extension follows the expiration the initial 180-calendar day compliance period on April 20, 2026.

SAN FRANCISCO, April 23, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release financial results for the first quarter of 2026 after market close on Thursday, May 14, 2026. Management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on May 14, 2026.

WALTHAM, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it has granted inducement equity awards to 18 new employees. The awards were made as an inducement material to the new employees’ acceptance of employment with Dyne in accordance with Nasdaq Listing Rule 5635(c)(4).

CEDARHURST, N.Y., April 23, 2026 (GLOBE NEWSWIRE) -- Postal Realty Trust, Inc. (NYSE: PSTL) (the “Company”), an internally managed real estate investment trust that owns and manages over 2,300 properties leased primarily to the United States Postal Service (the “USPS”), ranging from last-mile post offices to industrial facilities, announced today that it will report its financial results for the period ended March 31, 2026, on Tuesday, May 5, 2026, after market close.

FRAMINGHAM, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that it will report financial results for its first quarter ended March 31, 2026, on Thursday, May 7, 2026 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results.

WATERTOWN, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced it has appointed Jessica Chutter to its Board of Directors, effective June 8, 2026.

New York, New York, April 23, 2026 (GLOBE NEWSWIRE) -- ESH Acquisition Corp. (the “Company”) (Nasdaq: ESHA) announced today that the Company received a notice (the “Deficiency Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") stating that the Company has not yet filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the "Form 10-K"), and therefore no longer complies with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission.  The Deficiency Notice stated that the Company has 60 calendar days to submit a plan to regain compliance and, if Nasdaq accepts the plan, Nasdaq may grant the Company an exception of up to 180 calendar days from the due date of the Form 10-K, or until October 14, 2026, to regain compliance. The notice has no effect at this time on the listing of the Company's securities, which will continue to trade uninterrupted on the Nasdaq Capital Market under the symbol "ESHA" until the Record Date, as described below. 

WAUWATOSA, Wis., April 23, 2026 (GLOBE NEWSWIRE) -- Waterstone Financial, Inc. (NASDAQ: WSBF), holding company for WaterStone Bank, reported net income of $6.0 million, or $0.34 per diluted share, for the quarter ended March 31, 2026, compared to $3.0 million, or $0.17 per diluted share, for the quarter ended March 31, 2025. Net income totaled $7.7 million, or $0.44 per diluted share, for the quarter ended December 31, 2025.

NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) ("IREN") today announced that it will release its financial results for the three months ended March 31, 2026, on Thursday, May 7, 2026 and host a conference call beginning at 5:00 p.m. Eastern Time.

Businesses Can Now Accept Payments at Zero Cost with Full-Featured Gateway Including Surcharging, Dual Pricing, Instant Payouts, and White-Label Options

CEO Tim Young provides candid update on Austin pilot findings, manufacturing strategy, and the company’s dual-track technology roadmap

Cellular Wellness Company Recognized for Proprietary Formulations, Intellectual Property, and Scalable Manufacturing Excellence

Regeneron will provide Otarmeni™ (lunsotogene parvec-cwha), its recently approved gene therapy for an ultra-rare form of genetic hearing loss, for free in the U.S.

Stroger Hospital has the oldest comprehensive trauma unit in the country

The 2026 Neil Armstrong Space Prize was announced Tuesday (April 21) at Purdue University, heralding the Falcon 9 Booster Landing Team as the inaugural laureate of the Neil Armstrong Space Prize

New integration simplifies how members open and fund self-directed retirement accounts through the Crowd Street platform

Meet Rovey: the AI crew assistant that knows the difference between a Sea Terrace and a Brilliant Suite and makes planning feel like the start of something good

In a pivotal moment for American democracy, the organization endorses three battle-tested leaders shaping the country’s future.

The debut historical fiction novel from U.S. Air Force veteran Bernard Cuddy follows a college pitcher whose life is forever altered by the Vietnam War and his long fight to return to the mound.

Montvale, NJ, April 23, 2026 (GLOBE NEWSWIRE) -- Health Monitor Network, a trusted leader in point of care marketing and patient education, today announced that all 15 of its submissions to the 2026 Hermes Creative Awards received recognition, earning five Platinum Awards, five Gold Awards and five Honorable Mentions.